Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients (scientific article published on 27 August 2015)

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Q28303718

Nuclear factor-kappaB in cancer development and progression

Q29547879

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Q29614349

Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study

Q33509281

An integrated view of humoral innate immunity: pentraxins as a paradigm

Q34020449

Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients

Q34083517

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

Q34102992

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study

Q34150807

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

Q34403569

PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer

Q34462648

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history

Q34604212

Epidemiology and genetics of rheumatoid arthritis

Q34731244

CRP after 2004.

Q36097479

The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps

Q36229261

Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk

Q36360694

Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer

Q37032881

Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study

Q37297427

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer

Q37382538

The new lung cancer staging system

Q37543784

Chronic obstructive pulmonary disease and cardiovascular disease

Q38111151

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

Q38373761

Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma

Q43521840

Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions

Q44046799

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

Q46071688

TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK.

Q46844038

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

Q48458509

Regulation of leukocyte recruitment by the long pentraxin PTX3.

Q51774594

Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma.

Q53366492

Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma

Q57941010

P433

issue

P407

language of work or name

English

Q1860

P1104

number of pages

P304

page(s)

983-991

P577

publication date

2015-08-27

P1433

published in

International Journal of Cancer

Q332492

P1476

title

Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients

P478

volume

138

Reverse relations

cites work (P2860)

Q90481286	Cytokine TNF-α promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3
Q40258398	Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
Q94451862	PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma
Q50143105	PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer
Q40444488	Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial
Q41907221	Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study.
Q64083536	Pentraxin-3 and inflammatory biomarkers related to posterolateral thoracotomy in Thoracic Surgery
Q42505998	Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.
Q38991073	Pentraxins in the activation and regulation of innate immunity
Q47422499	Preoperative methylprednisolone increases plasma Pentraxin 3 early after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial.
Q55122117	SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.
Q89776625	Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma
Q91561559	Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfaces
Q33632047	The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?
Q64118817	The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
Q64076093	The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
Q48193738	The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis
Q33632041	The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling
Q94525807	Tumor Necrosis Factor Alpha-Induced Proteins in Malignant Tumors: Progress and Prospects